Adapalene
NDC Package 59726-888-05

11-digit billing NDC: 59726088805
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Adapalene is a medication used to treat acne. Marketed by P & L Development, Llc, this product is identified by NDC 59726-888 and is authorized under FDA application ANDA091314.

Identification & Billing

NDC Package Code
59726-888-05
Package Description
1 TUBE in 1 CARTON / 15 g in 1 TUBE
Product Code
59726-888
11-Digit Billing Format
59726088805

Clinical Specifications

Proprietary Name
Adapalene
Dosage Form
-
Usage Information
This medication is used to treat acne. It may decrease the number and severity of acne pimples and promote quick healing of pimples that do develop. Adapalene belongs to a class of medications called retinoids. It works by affecting the growth of cells and decreasing swelling and inflammation.

Regulatory & Marketing

Labeler Name
P & L Development, Llc
FDA Application #
ANDA091314
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-28-2021
End Marketing Date
09-01-2026
Listing Expiration
09-01-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59726-888-05 identifies a specific commercial package of 1 tube in 1 carton / 15 g in 1 tube of Adapalene, labeled by P & L Development, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by P & L Development, Llc on May 28, 2021. The current certification is valid through September 01, 2026.

What are the primary indications for this medication?

This medication is used to treat acne. It may decrease the number and severity of acne pimples and promote quick healing of pimples that do develop. Adapalene belongs to a class of medications called retinoids. It works by affecting the growth of cells and decreasing swelling and inflammation.

How is this P & L Development, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59726088805. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59726-888-05
11-Digit CMS (5-4-2)
59726-0888-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.